Osteopore Limited announced its Chief Technology Officer (CTO), Dr. Lim Jing, has been appointed as the Company's Chief Operating Officer (COO), effective 1 May 2022. As Chief Operations Officer, Dr. Lim Jing will be responsible for overseeing the daily business and administrative operations, assessing and enhancing the efficiency of internal and external operational processes, and collaborating with management and other stakeholders to identify initiatives to increase the value of the company. With over a decade of experience in tissue engineering research, and a deep understanding of the Company's novel technology, Dr. Lim Jing will also continue his role as Osteopore's Chief Technology Officer - in conjunction with the newly appointed role of Chief Operating Officer.